Abeona Therapeutics (ABEO) Stock Chart & Stock Price History $6.41 +0.05 (+0.79%) (As of 10/31/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Abeona Therapeutics Stock Price Performance5 Day Performance-3.08%1 Month Performance-0.32%3 Month Performance+28.57%6 Month Performance+52.17%Year-To-Date Performance+25.75%1 Year Performance+64.92% Receive ABEO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Abeona Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyBanking failure dead aheadIf you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now. ABEO Stock Chart for Thursday, October, 31, 2024 ABEO Chart by TradingView Abeona Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/30/2024$6.57$6.36-3.20%$6.64$6.29243,107 shs$260.53 million10/29/2024$6.39$6.57+2.82%$6.78$6.35500,323 shs$269.13 million10/28/2024$6.50$6.39-1.69%$6.68$6.34224,453 shs$261.75 million10/25/2024$6.34$6.50+2.52%$6.64$6.30163,088 shs$266.26 million10/24/2024$6.25$6.34+1.44%$6.47$6.12208,786 shs$259.71 million10/23/2024$6.57$6.25-4.87%$6.58$6.22205,215 shs$256.02 million Get the Latest News and Ratings for ABEO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Abeona Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/22/2024$6.55$6.57+0.31%$6.62$6.47107,048 shs$269.13 million10/21/2024$6.67$6.55-1.80%$6.74$6.5481,264 shs$268.31 million10/18/2024$6.74$6.67-1.04%$6.73$6.6382,011 shs$273.22 million10/17/2024$6.52$6.74+3.37%$6.78$6.43197,640 shs$276.09 million10/16/2024$6.54$6.52-0.31%$6.68$6.29234,669 shs$267.08 million10/15/2024$6.27$6.54+4.31%$6.55$6.15143,008 shs$267.90 million10/14/2024$6.41$6.27-2.18%$6.48$6.25215,813 shs$256.84 million10/11/2024$6.58$6.41-2.58%$6.59$6.40207,300 shs$277.62 million10/10/2024$6.64$6.58-0.90%$6.66$6.41375,543 shs$269.54 million10/09/2024$6.53$6.64+1.68%$6.67$6.39223,994 shs$271.99 million10/08/2024$6.54$6.53-0.15%$6.74$6.50177,580 shs$267.49 million10/07/2024$6.46$6.54+1.24%$6.73$6.39428,485 shs$267.90 million10/04/2024$6.38$6.46+1.25%$6.60$6.42184,583 shs$264.62 million10/03/2024$6.23$6.38+2.41%$6.42$6.17204,309 shs$261.34 million10/02/2024$6.46$6.23-3.56%$6.45$6.06302,273 shs$255.20 million10/01/2024$6.32$6.46+2.22%$6.48$6.08499,035 shs$264.62 million09/30/2024$5.89$6.32+7.30%$6.47$5.89402,442 shs$258.89 million09/27/2024$5.93$5.89-0.67%$6.22$5.86330,777 shs$241.27 million09/26/2024$5.93$5.93$6.04$5.76202,915 shs$256.83 million09/25/2024$5.76$5.93+2.95%$6.05$5.76306,380 shs$256.83 million09/24/2024$5.86$5.76-1.71%$5.94$5.69180,890 shs$235.95 million09/23/2024$6.02$5.86-2.66%$6.18$5.80309,797 shs$240.04 million09/20/2024$5.80$6.02+3.79%$6.02$5.72437,282 shs$246.60 million09/19/2024$5.45$5.80+6.42%$5.97$5.57516,826 shs$237.59 million09/18/2024$5.46$5.45-0.18%$5.61$5.43160,408 shs$223.25 million09/17/2024$5.33$5.46+2.44%$5.67$5.33181,045 shs$223.66 million09/16/2024$5.58$5.33-4.48%$5.69$5.32167,332 shs$230.84 million09/13/2024$5.58$5.58$5.75$5.53151,024 shs$241.67 million09/12/2024$5.59$5.58-0.18%$5.68$5.54105,517 shs$228.57 million09/11/2024$5.56$5.59+0.54%$5.61$5.4586,112 shs$242.10 million09/10/2024$5.62$5.56-1.07%$5.64$5.5281,799 shs$240.80 million09/09/2024$5.55$5.62+1.26%$5.77$5.57156,582 shs$243.40 million09/06/2024$5.63$5.55-1.42%$5.75$5.34193,184 shs$227.35 million09/05/2024$5.57$5.63+1.08%$5.68$5.46201,277 shs$230.62 millionBanking failure dead ahead (Ad)If you missed it, my emergency election broadcast is now available - but will be removed soonClick here to watch it now.09/04/2024$5.46$5.57+2.01%$5.61$5.33147,875 shs$228.16 million09/03/2024$5.70$5.46-4.21%$5.84$5.38230,983 shs$223.66 million09/02/2024$5.70$5.70$5.75$5.50180,000 shs$246.87 million08/30/2024$5.56$5.70+2.52%$5.75$5.50179,718 shs$233.49 million08/29/2024$5.54$5.56+0.36%$5.84$5.54239,324 shs$227.75 million08/28/2024$5.60$5.54-1.07%$5.66$5.37203,753 shs$226.94 million08/27/2024$5.74$5.60-2.44%$5.73$5.45189,677 shs$229.39 million08/26/2024$5.52$5.74+4.08%$5.76$5.49341,951 shs$235.13 million08/23/2024$5.12$5.52+7.71%$5.55$5.13337,658 shs$225.91 million08/22/2024$5.24$5.12-2.29%$5.26$5.08175,648 shs$209.73 million08/21/2024$5.13$5.24+2.14%$5.27$5.08197,979 shs$214.65 million08/20/2024$5.23$5.13-1.91%$5.34$5.05307,313 shs$210.14 million08/19/2024$5.00$5.23+4.60%$5.25$4.91285,202 shs$214.24 million08/16/2024$5.00$5.00$5.06$4.88161,187 shs$204.82 million08/15/2024$4.95$5.00+1.01%$5.31$4.94345,005 shs$204.82 million08/14/2024$4.98$4.95-0.60%$5.30$4.84411,017 shs$202.77 million08/13/2024$4.95$4.98+0.61%$5.08$4.81208,268 shs$204.00 million08/12/2024$4.42$4.95+11.99%$5.21$4.50600,396 shs$202.77 million08/09/2024$4.47$4.42-1.12%$4.57$4.36427,199 shs$181.06 million08/08/2024$4.42$4.47+1.13%$4.58$4.41204,765 shs$183.11 million08/07/2024$4.68$4.42-5.56%$4.82$4.41199,418 shs$181.06 million08/06/2024$4.60$4.68+1.74%$4.78$4.50232,878 shs$191.69 million08/05/2024$4.70$4.60-2.13%$4.70$4.30489,648 shs$188.42 million08/02/2024$4.81$4.70-2.29%$4.77$4.63330,228 shs$192.51 million08/01/2024$4.90$4.81-1.84%$4.94$4.73284,509 shs$197.02 million07/31/2024$4.72$4.90+3.81%$5.00$4.57355,560 shs$200.70 million07/30/2024$4.98$4.72-5.22%$5.01$4.71319,242 shs$193.33 million Related Companies uniQure Stock Price Chart Voyager Therapeutics Stock Price Chart Aclaris Therapeutics Stock Price Chart Equillium Stock Price Chart Lumos Pharma Stock Price Chart REGENXBIO Stock Price Chart OPKO Health Stock Price Chart ArriVent BioPharma Stock Price Chart Aurinia Pharmaceuticals Stock Price Chart Evolus Stock Price Chart Receive ABEO Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Abeona Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ABEO) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abeona Therapeutics Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Abeona Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.